Supplementary protection
LT - 8-[3-Amino-piperidin-1-il]-ksantinai, jų gavimas ir jų panaudojimas, kaip vaistų
EN - 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS MEDICAMENTS
SPC
| (11) |
Number of the document |
|
| (68) |
Number of the document |
1532149
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2012 022 |
| (22) |
Date of filing the application |
2012-12-21 |
| (41) |
Date of publication of the application |
2013-02-25 |
|
Date of publication of SPC |
|
| (24) |
Date of coming into effect of SPC |
|
Applicant
| (71) |
Boehringer Ingelheim Pharma GmbH & Co. KG,
55216 Ingelheim am Rhein,
DE
|
Grantee
| (73) |
Boehringer Ingelheim Pharma GmbH & Co. KG,
55216 Ingelheim am Rhein,
DE
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/12/780/001 - EU/1/12/780/034, 2012-07-20
|
Name of the product protected by the basic patent
| (95) |
Linagliptinum + Metformini hydrochloridum |
Legal status
|
SPC application rejecetd
|
|
